Comparison of Immediate Implant Placement With Titanium Mesh Versus Collagen Membrane in Type II Socket: A Randomized Clinical Trial
Launched by MISR INTERNATIONAL UNIVERSITY · Mar 9, 2025
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for placing dental implants immediately after removing badly broken maxillary (upper jaw) premolar teeth. The focus is on improving the bone support around the implant using two materials: titanium mesh and collagen membrane. The goal is to see which method helps maintain better bone thickness in the area where the tooth was removed.
To be part of this study, participants should be between 21 and 50 years old, have at least one broken or decayed tooth in the front upper jaw, and be in good overall health. They should also have good oral hygiene and be willing to follow up with the research team. However, people who smoke, have certain dental habits that could harm the implant, or are pregnant or nursing cannot participate. If eligible, participants can expect to receive an implant and will be monitored to see how well the bone heals around it using the different materials.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who have at least one remaining root or badly decayed tooth in anterior maxilla.
- • 2. Systemically free patients (American Society of Anesthesiologists I; ASA I)
- • 3. Patients aged from 21 to 50 years old
- • 4. Buccal bone partial deficiency (extraction socket type II)
- • 5. Good oral hygiene
- • 6. Accepts the follow-up period (cooperative patients)
- • 7. Patient accepts to provides an informed consent
- Exclusion Criteria:
- • 1. Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits such as bruxism
- • 2. Smokers
- • 3. Pregnant and lactating females
About Misr International University
MISR International University is a distinguished educational institution dedicated to advancing health sciences and clinical research. As a clinical trial sponsor, the university emphasizes innovative methodologies and rigorous scientific standards to enhance the quality of healthcare solutions. Committed to fostering collaboration between academia and industry, MISR International University actively engages in clinical trials that aim to address pressing medical challenges while ensuring ethical practices and patient safety. Through its comprehensive approach, the university seeks to contribute significantly to the body of clinical knowledge and improve health outcomes in the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
ahmed H Farid, Masters
Principal Investigator
Assistant lecturer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported